Literature DB >> 21484126

Risk factors for mortality in cirrhotic patients with sepsis.

Lee-Guan Lim1, Xiang-Xuan Eunice Tan, Shu-Jeng Woo, Yock-Young Dan, Yin-Mei Lee, Vincent Lai, Seng-Gee Lim.   

Abstract

BACKGROUND: Patients with cirrhosis and sepsis had increased mortality. AIM: Determine factors associated with increased in-hospital mortality in cirrhotic patients admitted for sepsis.
METHODS: All cirrhotic patients admitted from 2004 to 2007 for sepsis were identified from hospital electronic database. Patients were included if they had liver cirrhosis and sepsis, defined as identified sources of infection, and at least one of fever, altered total white cell count, or raised C-reactive protein. Baseline characteristics, investigations, infections, and outcomes were collected. Main outcome measure was in-hospital mortality.
RESULTS: A total of 205 admissions in 153 patients were included. In-hospital mortality rate was 24.4%. In predicting in-hospital death, area under the receiver-operating-characteristic curve for Child-Pugh score was 0.934, with optimum cut-off at 10 and above, while for model for end-stage liver disease (MELD) score was 0.751, with optimum cut-off at 17 and above. Four factors were significantly associated with in-hospital mortality on multivariate analysis: presence of >1 site of infection, pneumonia, Child's C status, and MELD score 17 and above. In-hospital mortality rate increased with more factors: 0% with no factor, 7% with one factor, 21% with two factors, 87% with three factors, and 100% with four factors. The mortality of those with <3 risk factors was significantly lower than those with three or more risk factors (7 vs. 91%, p = 0.000).
CONCLUSIONS: Septic cirrhotic patients with pneumonia, >1 site of infection, Child's C cirrhosis, and high MELD score had a high mortality risk.

Entities:  

Year:  2011        PMID: 21484126     DOI: 10.1007/s12072-011-9258-y

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  29 in total

Review 1.  New guidelines for the management of adult community-acquired pneumonia.

Authors:  Kathryn Armitage; Mark Woodhead
Journal:  Curr Opin Infect Dis       Date:  2007-04       Impact factor: 4.915

Review 2.  Diagnosis and treatment of uncomplicated urinary tract infection.

Authors:  T M Hooton; W E Stamm
Journal:  Infect Dis Clin North Am       Date:  1997-09       Impact factor: 5.982

Review 3.  Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.

Authors:  F Wong; M Bernardi; R Balk; B Christman; R Moreau; G Garcia-Tsao; D Patch; G Soriano; J Hoefs; M Navasa
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

4.  Bacterial translocation of enteric organisms in patients with cirrhosis.

Authors:  I Cirera; T M Bauer; M Navasa; J Vila; L Grande; P Taurá; J Fuster; J C García-Valdecasas; A Lacy; M J Suárez; A Rimola; J Rodés
Journal:  J Hepatol       Date:  2001-01       Impact factor: 25.083

5.  Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU.

Authors:  A Aggarwal; J P Ong; Z M Younossi; D R Nelson; L Hoffman-Hogg; A C Arroliga
Journal:  Chest       Date:  2001-05       Impact factor: 9.410

Review 6.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

7.  A prospective study of bacterial infections in patients with cirrhosis.

Authors:  W R Caly; E Strauss
Journal:  J Hepatol       Date:  1993-07       Impact factor: 25.083

8.  Human alveolar macrophage antibacterial activity in the alcoholic lung.

Authors:  B Wallaert; C Aerts; J F Colombel; C Voisin
Journal:  Am Rev Respir Dis       Date:  1991-08

9.  Acid-suppressive medication use and the risk for hospital-acquired pneumonia.

Authors:  Shoshana J Herzig; Michael D Howell; Long H Ngo; Edward R Marcantonio
Journal:  JAMA       Date:  2009-05-27       Impact factor: 56.272

10.  Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites.

Authors:  José Such; Rubén Francés; Carlos Muñoz; Pedro Zapater; Juan A Casellas; Ana Cifuentes; Francisco Rodríguez-Valera; Sonia Pascual; Javier Sola-Vera; Fernando Carnicer; Francisco Uceda; José M Palazón; Miguel Pérez-Mateo
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

View more
  1 in total

Review 1.  Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Ying Peng; Xingshun Qi; Xiaozhong Guo
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.